{
    "N/R/U": null,
    "Applicant": "Theratechnologies Inc.",
    "BLA Number": "022505",
    "Proprietary Name": "Egrifta SV",
    "Proper Name": "tesamorelin",
    "BLA Type": "351(a)",
    "Strength": "2MG ",
    "Dosage Form": "For Injection",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "November 29, 2011",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "1",
    "Submission Type": "Supplement",
    "License Number": "2091",
    "Product Number": "002",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}